[Specific modification of the coenzyme binding site of dehydorgenases by inhibition with the NAD analogue (3-(4-bromoacetylpyridinio)propyl)-adenosine pyrophosphate].
D000429:Alcohol Oxidoreductases / Q000037:antagonists & inhibitors*; D001665:Binding Sites / Q000187:drug effects*; D003067:Coenzymes / Q000037:antagonists & inhibitors*; D011756:Diphosphates / Q000138:chemical synthesis / Q000494:pharmacology*; D000431:Ethanol; D005985:Glyceraldehyde; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors*; D006863:Hydrogen-Ion Concentration; D007770:L-Lactate Dehydrogenase / Q000037:antagonists & inhibitors*; D007773:Lactates; D009243:NAD; D013438:Sulfhydryl Compounds / Q000032:analysis
D003067:Coenzymes; D011756:Diphosphates; D007773:Lactates; D013438:Sulfhydryl Compounds; D009243:NAD; D005985:Glyceraldehyde; D000431:Ethanol; D000429:Alcohol Oxidoreductases; D007770:L-Lactate Dehydrogenase; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases
Spezifische Modifizierung der Coenzymbindungsstelle von Dehydrogenasen mit dem NAD-ähnlichen Inaktivator (3-(4-Bromacetylpyridinio)propyl)-adenosin-pyrophosphat.